secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001854270-23-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director David R. Epstein resigns from Senti board effective June 16, 2023
--------------------------------------------------------------------------

- David R. Epstein resigned as director and from all board committees, effective June 16, 2023.
- Resignation to avoid potential conflict with his role as CEO of Seagen, Inc.
- No disagreement with Senti's operations, policies, or practices cited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427023000044/0001854270-23-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427023000044/snti-20230428.htm
  HTML page:      https://secwatch.observer/filing/0001854270-23-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer